A paradigm shift in the diagnosis of prostate cancer
Inify, ContextVision’s first digital pathology product for diagnosis of prostate cancer using deep learning and artificial intelligence, is on track regarding commercialisation.
Hosted on Acast. See acast.com/privacy for more information.
A paradigm shift in the diagnosis of prostate cancer
Inify, ContextVision’s first digital pathology product for diagnosis of prostate cancer using deep learning and artificial intelligence, is on track regarding commercialisation.
Hosted on Acast. See acast.com/privacy for more information.